scispace - formally typeset
S

Siddig Ibrahim Abdelwahab

Researcher at Jazan University

Publications -  150
Citations -  4361

Siddig Ibrahim Abdelwahab is an academic researcher from Jazan University. The author has contributed to research in topics: Apoptosis & Medicine. The author has an hindex of 36, co-authored 129 publications receiving 3544 citations. Previous affiliations of Siddig Ibrahim Abdelwahab include University of Malaya & Universiti Putra Malaysia.

Papers
More filters
Journal ArticleDOI

Thymoquinone Induces Mitochondria-Mediated Apoptosis in Acute Lymphoblastic Leukaemia in Vitro

TL;DR: Thymoquinone (TQ) is an active ingredient isolated from Nigella sativa and it is indicated that TQ could be a promising agent for the treatment of leukemia.
Journal ArticleDOI

Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia.

TL;DR: In this article, a cross-sectional, retrospective study using an online questionnaire was conducted among COVID-19 vaccines recipients in Saudi Arabia, and vaccine-associated side effects after receiving at least one dose of each vaccine were evaluated.
Journal ArticleDOI

Antisecretory, Gastroprotective, Antioxidant and Anti-Helicobcter Pylori Activity of Zerumbone from Zingiber Zerumbet (L.) Smith

TL;DR: It is revealed that zerumbone promotes ulcer protection, which might be attributed to the maintenance of mucus integrity, antioxidant activity, and HSP-70 induction.
Journal ArticleDOI

Gastroprotective activity and mechanism of novel dichlorido-zinc(II)-4-(2-(5-methoxybenzylideneamino)ethyl)piperazin-1-iumphenolate complex on ethanol-induced gastric ulceration.

TL;DR: The findings suggest that the gastroprotective activity of ZnHMS might contribute in adjusting the inflammatory cytokine-mediated oxidative damage to the gastric mucosa.
Journal ArticleDOI

Typhonium flagelliforme induces apoptosis in CEMss cells via activation of caspase-9, PARP cleavage and cytochrome c release: Its activation coupled with G0/G1 phase cell cycle arrest

TL;DR: Results presented in this study demonstrated that the DCM/F7 fraction inhibited the proliferation of leukemia cells, leading to the programmed cell death, which was confirmed to be through the mitochondrial pathway.